Premium
Trends in the use of selective serotonin reuptake inhibitors in nine department of veterans affairs outpatient facilities
Author(s) -
Voris John C.
Publication year - 1999
Publication title -
journal of clinical psychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.124
H-Index - 119
eISSN - 1097-4679
pISSN - 0021-9762
DOI - 10.1002/(sici)1097-4679(199901)55:1<129::aid-jclp13>3.0.co;2-0
Subject(s) - fluoxetine , paroxetine , veterans affairs , sertraline , medical prescription , serotonin reuptake inhibitor , reuptake inhibitor , medicine , serotonin , psychiatry , pharmacology , psychology , antidepressant , anxiety , receptor
The average daily dose and need for dose escalations for the drugs known as selective serotonin reuptake inhibitors (SSRI s ) has frequently been a point of controversy. This study reports on the information gathered from nine Veterans Affairs hospitals over a two six‐month periods. Average daily doses of fluoxetine, paroxetine, and sertraline started at 30.9 mg, 24.2 mg, and 87.8 mg and ended at 28.4 mg, 24.2 mg, and 89.8 mg, respectively. Cost, number of prescriptions, and dosage strength data is also presented. © 1999 John Wiley & Sons, Inc. J Clin Psychol 55: 129–133, 1999.